Posted on February 20, 2018 PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals Read More
Posted on October 5, 2017 PENDOPHARM launches GLATECT, a new treatment option for MS patients Read More
Posted on September 22, 2017 PENDOPHARM, a division of Pharmascience Inc., Invests in Ontario based Edesa Biotech and Licenses Three Novel Anorectal Treatments for Canada Read More
Posted on April 14, 2016 PENDOPHARM to Promote Entocort® (budesonide) within Canada for Tillotts Pharma AG Read More
Posted on November 24, 2015 CANADIAN FOOTBALL LEAGUE BRINGS ATTENTION TO PLAYER HEALTH THROUGH MULTI-YEAR MARKETING PARTNERSHIP WITH MONOVISC® Read More